MHRA guidance note 14 on the supply of unlicensed medicinal products (‘specials’) updated

The MHRA guidance on the supply of unlicensed medicinal products (‘specials’) has been updated. This guidance has been updated following the consolidation of medicines legislation into the Human Medicines Regulations 2012 and takes into account the outcomes of relevant European court cases. Read more “MHRA guidance note 14 on the supply of unlicensed medicinal products (‘specials’) updated”